Naptumomab

About Active Biotech

Active Biotech is a Swedish biopharmaceutical company focused on modulating the immune system to treat cancer and inflammatory eye diseases. Its strategy centers on repurposing and advancing a portfolio of assets with extensive prior clinical data, including tasquinimod for hematological cancers and laquinimod for uveitis, to achieve efficient development in high-value niches. The company maintains a lean operational model, with key programs either fully owned or strategically partnered, such as naptumomab with NeoTX for solid tumors.

Therapeutic Areas